{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Potential failure of vaccine efficacy in later clinical trials\",\"Impact\":\"Delay in vaccine development and population immunity, leading to prolonged spread of the disease\",\"Mitigation\":\"Conduct thorough pre-clinical testing, closely monitor adverse effects, and continue to improve vaccine design\",\"Technologies\":\"Advanced testing methods, data analytics for adverse event monitoring\",\"People\":\"Clinical trial participants, general population\",\"Owner\":\"Vaccine developers, regulatory authorities, public health organizations\"},{\"Description\":\"Inadequate public trust in traditional vaccine development methods\",\"Impact\":\"Reduced uptake of vaccines, hindering efforts to achieve herd immunity\",\"Mitigation\":\"Transparent communication, education on vaccine safety and efficacy, community engagement\",\"Technologies\":\"Interactive communication platforms, social media monitoring\",\"People\":\"General population, healthcare providers\",\"Owner\":\"Public health authorities, communication experts, healthcare organizations\"},{\"Description\":\"Global collaboration and resource allocation challenges\",\"Impact\":\"Delays in vaccine development, unequal access to vaccines, and limited support in outbreak regions\",\"Mitigation\":\"Establish clear international cooperation frameworks, allocate resources based on need and urgency, support capacity building in low-resource settings\",\"Technologies\":\"International collaboration platforms, supply chain management systems, data-driven resource allocation tools\",\"People\":\"Global health organizations, low-resource countries, vaccine manufacturers\",\"Owner\":\"International health organizations, government agencies, philanthropic organizations\"}]}"}}